According to AlphaMoat, in October 2026 ImpriMed (imprimedicine.com) received 58,891 monthly visits (+25.9% MoM) — ranked #4,501 of 17,609 AI websites with traffic data, and #507 of 3,112 in Industry Services; its largest market is United States (49.2% of visits).
ImpriMed is an AI precision-medicine company for veterinary oncology that helps doctors match the most suitable drugs for blood cancers in dogs and cats.
It provides precision-medicine analysis and CRO services to veterinary oncology clinics, hospitals, and human-oncology pharmaceutical companies.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 58.6K | — |
| 2026-07 | 50.3K | -14.3% |
| 2026-08 | 49.2K | -2.1% |
| 2026-09 | 46.8K | -4.9% |
| 2026-10 | 58.9K | +25.9% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, ImpriMed (imprimedicine.com) received 58,891 visits (about 58.9K) in October 2026 (+25.9% month over month), ranking #4,501 of 17,609 AI websites with traffic data, and #507 in Industry Services.
In October 2026, ImpriMed’s largest markets by share of visits are United States 49.2%, South Korea 14.6%, Canada 9.0%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.